Skimming the Sun, probe sheds light on space weather threats
Captured by the Parker Solar Probe during its closest approach to our star starting on December 24, 2024, the images were recently released by NASA and are expected to deepen our understanding of space weather and help guard against solar threats to Earth.
- A historic achievement –
"We have been waiting for this moment since the late Fifties," Nour Rawafi, project scientist for the mission at the Johns Hopkins Applied Physics Laboratory, told AFP.
Previous spacecraft have studied the Sun, but from much farther away.
Parker was launched in 2018 and is named after the late physicist Eugene Parker, who in 1958 theorized the existence of the solar wind -- a constant stream of electrically charged particles that fan out through the solar system.
The probe recently entered its final orbit where its closest approach takes it to just 3.8 million miles from the Sun's surface -- a milestone first achieved on Christmas Eve 2024 and repeated twice since on an 88-day cycle.
To put the proximity in perspective: if the distance between Earth and the Sun measured one foot, Parker would be hovering just half an inch away.
Its heat shield was engineered to withstand up to 2,500 degrees Fahrenheit (1,370 degrees Celsius) -- but to the team's delight, it has only experienced around 2,000F (1090C) so far, revealing the limits of theoretical modeling.
Remarkably, the probe's instruments, just a yard (meter) behind the shield, remain at little more than room temperature.
- Staring at the Sun –
The spacecraft carries a single imager, the Wide-Field Imager for Solar Probe (WISPR), which captured data as Parker plunged through the Sun's corona, or outer atmosphere.
Stitched into a seconds-long video, the new images reveal coronal mass ejections (CMEs) -- massive bursts of charged particles that drive space weather -- in high resolution for the first time.
"We had multiple CMEs piling up on top of each other, which is what makes them so special," Rawafi said. "It's really amazing to see that dynamic happening there."
Such eruptions triggered the widespread auroras seen across much of the world last May, as the Sun reached the peak of its 11-year cycle.
Another striking feature is how the solar wind, flowing from the left of the image, traces a structure called the heliospheric current sheet: an invisible boundary where the Sun's magnetic field flips from north to south.
It extends through the solar system in the shape of a twirling skirt and is critical to study, as it governs how solar eruptions propagate and how strongly they can affect Earth.
- Why it matters –
Space weather can have serious consequences, such as overwhelming power grids, disrupting communications, and threatening satellites.
As thousands more satellites enter orbit in the coming years, tracking them and avoiding collisions will become increasingly difficult -- especially during solar disturbances, which can cause spacecraft to drift slightly from their intended orbits.
Rawafi is particularly excited about what lies ahead, as the Sun heads toward the minimum of its cycle, expected in five to six years.
Historically, some of the most extreme space weather events have occurred during this declining phase -- including the infamous Halloween Solar Storms of 2003, which forced astronauts aboard the International Space Station to shelter in a more shielded area.
"Capturing some of these big, huge eruptions...would be a dream," he said.
Parker still has far more fuel than engineers initially expected and could continue operating for decades -- until its solar panels degrade to the point where they can no longer generate enough power to keep the spacecraft properly oriented.
When its mission does finally end, the probe will slowly disintegrate -- becoming, in Rawafi's words, "part of the solar wind itself."
ia/jgc
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Updated Data from Eledon Pharmaceuticals' Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation to be Presented at the World Transplant Congress 2025
IRVINE, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. ('Eledon') (Nasdaq: ELDN) today announced that updated clinical data from its ongoing open-label Phase 1b study evaluating tegoprubart for the prevention of rejection in subjects undergoing kidney transplantation will be presented at the World Transplant Congress (WTC) taking place in San Francisco from August 2-6, 2025. The oral presentation will feature updated results from approximately 30 kidney transplant recipients and will be presented by Dr. John Gill from the University of British Columbia. Details of the oral presentation are as follows: Title: Tegoprubart, an Anti-CD40L Antibody, for the Prevention of Rejection in Kidney Transplantation: An Ongoing Phase 1b StudySession: Oral Presentation, Kidney Novel Immunosuppressant StrategiesPresenter: John Gill, MD, MS, University of British Columbia, Vancouver, CanadaSession Date and Time: Wednesday, August 6, 2025: 10:00 a.m. – 11:15 a.m. PT Following the session, a copy of the presentation can be found on the Investor section of the Company's website at The Company will also sponsor a satellite symposium at WTC titled: 'What Truly Defines Kidney Transplant Success: Early Rejection or Lasting Function?', to be held on Sunday, August 3, at 1:00 pm PT. Faculty include Allan Kirk, MD, Duke University School of Medicine, Oriol Bestard, MD, PhD, MD, Vall d'Hebron University Hospital, John Gill, MD, MS, University of British Columbia, Alexandre Loupy, MD, PhD, Necker Hospital and Deirdre Sawinski, MD, Weill Cornell Medical College. In addition to the oral presentation, new preclinical data, utilizing tegoprubart for the prevention of rejection in non-human primates undergoing liver transplantation, will be presented by Dr. Andrew Adams in a poster session: Title: Anti-CD154 Facilitates Long-Term Liver Allograft Survival in Non-Human PrimatesSession: Poster PresentationPresenter: Andrew Adams, MD, PhD, University of MinnesotaDate and Time: Sunday, August 3, 2025, 3:30 p.m. PT About Eledon Pharmaceuticals and tegoprubart Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company that is developing immune-modulating therapies for the management and treatment of life-threatening conditions. The Company's lead investigational product is tegoprubart, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential. The central role of CD40L signaling in both adaptive and innate immune cell activation and function positions it as an attractive target for non-lymphocyte depleting, immunomodulatory therapeutic intervention. The Company is building upon a deep historical knowledge of anti-CD40 Ligand biology to conduct preclinical and clinical studies in kidney allograft transplantation, xenotransplantation, and amyotrophic lateral sclerosis (ALS). Eledon is headquartered in Irvine, California. For more information, please visit the Company's website at Follow Eledon Pharmaceuticals on social media: LinkedIn; Twitter Investor Contact: Stephen JasperGilmartin Group(858) 525 2047stephen@ Media Contact: Jenna UrbanCG Life(212) 253 8881jurban@ Source: Eledon Pharmaceuticals


Gizmodo
an hour ago
- Gizmodo
Flesh-Eating Bacteria Have Already Killed Four People in Florida This Year
A rare flesh-eating bacteria has killed four people in Florida this year, according to a recent report by the state's Department of Health. The deadly bacteria, Vibrio vulnificus, is typically found in warm saltwater or brackish water. It can enter the body through open cuts or by consuming raw shellfish, and the microbe is often found in oysters from warm coastal waters. Although infections are rare, the bacterium causes a disease called vibriosis, which is marked by gastrointestinal symptoms, fever, high heart rate, and disorientation. In some cases, it can lead to necrotizing fasciitis, a condition in which bacteria rapidly destroy muscle and tissue. According to the CDC, many people with Vibrio vulnificus infections require intensive care or even limb amputation. Roughly one in five people who contract a Vibrio vulnificus infection die, and people with weakened immune systems are particularly at risk. Florida has reported 11 cases this year. Around 150 to 200 cases of Vibrio vulnificus are reported to the CDC each year in the U.S., although experts believe the actual number may be higher. Cases have been on the rise in recent years. In 2022 and 2024, deaths and infections spiked after Hurricanes Helene and Milton, which washed saltwater inland. The department reported a record 19 deaths and 82 cases last year, an increase of seven deaths and nearly double the number of cases in 2023. For Vibrio vulnificus, another bacteria in the Vibrio family (who are generally less deadly), temperature and salinity are key growth factors, conditions that are becoming more common due to climate change, according to a report in Scientific American. Rising global temperatures also mean that hurricanes will become more frequent and stronger. A report by the U.S. Department of Agriculture stated that climate change will increase the cost of Vibrio infections from $2.6 billion in 1995 to between $6.1 and $8.6 billion by 2090. Worryingly, the microbes are extremely adaptable and can frequently acquire new traits. A 2023 study found that Vibrio pathogens are adapting to 'stick' to microplastics, for example. Florida Health officials caution against entering warm saltwater or brackish water if any fresh cuts, scrapes, or wounds are present. Consuming raw shellfish is also not recommended, unfortunately.


CNN
an hour ago
- CNN
New images reveal stunning views from mission to ‘touch' the sun
NASA released the closest-ever images of the sun's atmosphere. CNN's Jackie Wattles explains what scientists could learn from them.